ZyCoV-D plasmid DNA COVID vaccine efficacious, safe: Lancet on Phase 3 trials

Zydus, sharing the findings with the BSE, pointed out that the trial was conducted during the peak of the second wave of the COVID-19 infection.

Related Keywords

India ,Zydus Cadila ,Narendra Modi ,Sharvil Patel ,Zydus Lifesciences Ltd ,Delta Variant ,Managing Director ,Prime Minister Narendra Modi ,Emergency Use Authorisation ,Zycovd Plasmid Dna Covid Vaccine ,Zydus Vaccine ,Ydus Plasmid Vaccine ,Zydus Covid 19 Vaccine ,Ydus Dna Vaccine ,Ycovd Vaccine Phase 3 Trials ,Ycovd Lancet Report ,